EcoDrugPlus

Kinase Insert Domain Receptor

Ensembl ID : ENSAMXG00000043598
Gene Symbol: KDR
3 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSAMXG00000011281
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSAMXG00000012765
Gene Symbol: KIF5B
1 Cross references
275 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSAMXG00000005869
Gene Symbol: KIF5B
3 Cross references
274 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSAMXG00000003938
Gene Symbol: LTA4H
1 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSAMXG00000029069
Gene Symbol: LOC103028152
3 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSAMXG00000003120
Gene Symbol: LOC103028952
3 Cross references
167 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSAMXG00000030787
Gene Symbol: LOC103027614
3 Cross references
143 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSAMXG00000020390
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2b

Ensembl ID : ENSAMXG00000024252
Gene Symbol: LOC103031258
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSAMXG00000020519
Gene Symbol: LOXL2A
1 Cross references
210 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSAMXG00000035024
Gene Symbol: MIF
3 Cross references
235 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).